We already have an "exclusive Distribution and Supply Agreement with American Regent, Inc. (“American Regent”) for the distribution of leronlimab for the treatment of COVID-19 in the United States."

American Regent is a subsidiary of Daiichi Sankyo, the 2nd largest pharma in Japan. Daiichi has plenty of horsepower globally (my wife was an oncology rep many yrs ago).